Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TAS-0728 by Taiho Pharmaceutical for Biliary Tumor: Likelihood of Approval
TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Biliary Tumor. According to GlobalData, Phase...
TAS-0728 by Taiho Pharmaceutical for Gastric Cancer: Likelihood of Approval
TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
TAS-0728 by Taiho Pharmaceutical for Endometrial Cancer: Likelihood of Approval
TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...
TAS-0728 by Taiho Pharmaceutical for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to...
TAS-0728 by Taiho Pharmaceutical for Solid Tumor: Likelihood of Approval
TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
TAS-0728 by Taiho Pharmaceutical for Colorectal Cancer: Likelihood of Approval
TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...